Liste des médicaments et vaccins
DESIGNATION | DCI | TITULAIRE AMM | PAYS D'ORIGINE | PGHT(FCFA) | N°AMM | DATE EXPIRATION AMM |
---|---|---|---|---|---|---|
DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR 50mg+300mg+300mg Comprimé pelliculé B/30 | DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR | CIPLA QUALITY CHEMICAL INDUSTRIES LIMITED | Inde | 16398.93 | AMM_2021_11448 | 2027-07-31 |
DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR 50mg+300mg+300mg Comprimé B/30 | DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR | CIPLA QUALITY CHEMICAL INDUSTRIES LTD | Inde | 16398.93 | AMM_2021_11448 | 2027-07-31 |
DEPOFEM 150mg/mL Suspension injectable en flacon B/20 | MEDROXYPROGESTERONE | INCEPTA PHARMACEUTICALS LTD | Bangladesh | 11997.45 | AMM_2022_13460 | 2027-07-31 |
DEPOFEM 150mg/mL Suspension injectable en flacon B/1 | MEDROXYPROGESTERONE | INCEPTA PHARMACEUTICALS LTD | Bangladesh | 596.92 | AMM_2022_13461 | 2027-07-31 |
BRONQUIDIAZINA (80mg+400mg+4mg+250mg+325mg)/7,5Ml Suspension buvable Fl/150 mL | TRIMETHOPRIME + SULFAMETHOXAZOLE + CHLORHYDRATE DE BROMHEXINE + BENZOATE DE SODIUM + SIROP DE BAUME DE TOLU | FAES FARMA, S.A. | Espagne | 1443.25 | 6065/07 | 2027-07-31 |
ASPIRINE UPSA TAMPONNEE EFFERVESCENT 1000mg Comprimé effervescent B/20 | ACIDE ACETYLSALICYLIQUE | UPSA SAS | France | 1370.95 | 4788_02 | 2027-07-31 |
ACUDROX 250 250mg/5mL Suspension buvable Fl/30 mL | CEFADROXIL | MACLEODS PHARMACEUTICAL LTD. | Inde | 721.55 | 6338/07 | 2027-07-31 |
AARLEFLOX 500mg Comprimé pelliculé B/6 | LEVOFLOXACINE | PINNACLE LIFE SCIENCE PVT. LTD, | Inde | 1967.87 | AMM_2021_10209 | 2027-07-31 |
ROSEB 10/10 10mg+10mg Comprimé pelliculé B/30 | ROSUVASTATINE + EZETIMIBE | EXPHA LTD | Grèce | 7805.89 | AMM_2021_10573 | 2027-07-31 |
ROSEB 20/10 20mg+10mg Comprimé pelliculé B/30 | ROSUVASTATINE + EZETIMIBE | EXPHA LTD | Grèce | 9839.36 | AMM_2021_10579 | 2027-07-31 |